Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Safety, Efficacy and Total Cost of Therapy of Decentralized, Point-of-Care Manufactured Anti-CD19 CAR-T Cells for Relapsed or Refractory B Cell Leukemia and Lymphoma: Results from the First Phase 1 Indian Trial (VELCART)

Palani Hamenth Kumar, Arun Kumar Arunachalam, Mohammed Yasar, Phaneendra Venkateswara Rao Datari, Uday Kulkarni, Sushil Selvarajan, Anu Korula, Aby Abraham, Biju George, Vikram Mathews

Blood (2024) 144 (Supplement 1): 2090.

https://doi.org/10.1182/blood-2024-201902

Published: 2024

Journal Articles

Factor VIII Expression from a Novel F8 Transgene through a Lentiviral Vector Transduced CD34+ Autologous Hematopoietic Stem Cells for Gene Therapy of Severe Hemophilia Α: Final Results from a Phase 1 Clinical Trial

Blood (2024) 144 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2024-202882

Published: 2024

Journal Articles

Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma

Anu Korula, Arun Arunachalam, Uday Kulkarni, Phaneendra Venkateswara Rao Datari, Sumith Mathew, Aswin Anand PAI, Sushil Selvarajan, Fouzia N., Aby Abraham, Biju George, Poonkuzhali Balasubramanian, Vikram Mathews

Blood (2024) 144 (Supplement 1): 647.

https://doi.org/10.1182/blood-2024-201172

Published: 2024

Journal Articles

Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Chirag Trivedi, Sujith Kumar, Sushil Selvarajan, Sharon Anbumalar Lionel, Anup J Devasia, Fouzia N., Uday Kulkarni, Aby Abraham, Alok Srivastava, Biju George, Vikram Mathews, Anu Korula

Blood (2024) 144 (Supplement 1): 3048.

https://doi.org/10.1182/blood-2024-198979

Published: 2024

Journal Articles

Impact of Consolidation Radiotherapy in Bulky Diffuse Large B Cell Lymphoma By PET Based Response Assessment

Blood (2024) 144 (Supplement 1): 3078.

https://doi.org/10.1182/blood-2024-203645

Published: 2024

Journal Articles

EASIX d0 Predicts Early Transplant-Related Mortality in Patients Undergoing Haploidentical Transplantation with Post-Transplant Cyclophosphamide-Mycophenolate Mofetil-Based GvHD Prophylaxis

Aswin Anand Pai, Nieshanth Parthiban, Nayanthara Bijukumar, Rachel Mariam Renji, Manoj A, Sujith Karumathil, Kavitha M Lakshmi, Sushil Selvarajan, Anu Korula, Fouzia NA, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George, Uday Kulkarni, Poonkuzhali Balasubramanian

Blood (2024) 144 (Supplement 1): 4879.

https://doi.org/10.1182/blood-2024-201901

Published: 2024

Journal Articles

Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification

Aswin Anand Pai, John C Panetta, Nayanthara Bijukumar, Rachel Mariam Renji, Manoj A, Agila Jayaraman, Sujith Karumathil, Anu Korula, Sushil Selvarajan, Alok Srivastava, Aby Abraham, Vikram Mathews, Biju George, Uday Kulkarni, Poonkuzhali Balasubramanian

Blood (2024) 144 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2024-203105

Published: 2024

Journal Articles

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Vikram Mathews, Uday Kulkarni, Sushil Selvarajan, Nutan Damodar Joshi, Fouzia NA, Anu Korula, Sharon Anbumalar Lionel, Kavitha M Lakshmi, Alok Srivastava, Biju George, Aby Abraham

Blood (2023) 142 (Supplement 1): 4907.

https://doi.org/10.1182/blood-2023-188868

Published: 2023

Journal Articles

Patterns of Care and Outcome in Adolescent and Young Adults (AYA) Lymphomas- a Multicenter HCC (Hematologic Cancer Consortium) Registry Study from India

Lingaraj Nayak, Sushil Selvarajan, Hasmukh Jain, Parathan Karunakaran, Prasanth Ganesan, Jayachandran Perumal Kalaiyarasi, Nikita Mehra, Anu Korula, Uday Kulkarni, Aby Abraham, Alok Parekh, Ritam Joarder, Santhosh Kumar Devadas, Jina Bhattacharyya, Dubashi Biswajit, Vineetha Raghavan, Mobin Paul

Blood (2023) 142 (Supplement 1): 2412.

https://doi.org/10.1182/blood-2023-185774

Published: 2023

Journal Articles

Outcomes of Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia: An Indian Multi-Institution, Prospective Study from the Haematology Cancer Consortium (HCC)

Prasanth Ganesan, Mehak Trikha, Hasmukh Jain, Uday Prakash Kulkarni, Sushil Selvarajan, Anu Korula, Parathan Karunakaran, Smitha Carol Saldanha, Smita Kayal, Sadashivudu Gundeti, Gaurav Chatterjee, Praveen Kumar Shenoy, Dhanlaxmi Lalit Shetty, Rajan Kapoor, Rasmi Palassery, Mobin Paul, Om Prakash, Maya P Ganesan, Prasanna Samuel

Blood (2023) 142 (Supplement 1): 5821.

https://doi.org/10.1182/blood-2023-186743

Published: 2023

Journal Articles

Outcomes and Prognostic Factors in Patients with Primary Mediastinal B Cell Lymphoma: An Experience from Hematology Cancer Consortium

Akhil Rajendra, Alok Shetty, Anu Korula, Hasmukh Jain, Mobin Paul, Prasanth Ganesan, Jayachandran Perumal Kalaiyarasi, Santhosh Kumar Devadas, Sushil Selvarajan, Abhilash Menon, Divya K, Parathan Karunakaran, Lingaraj Nayak, Om Prakash, Bhausaheb Bagal, Aby Abraham, Prasanna Samuel, Uday Kulkarni

Blood (2023) 142 (Supplement 1): 3141.

https://doi.org/10.1182/blood-2023-186670

Published: 2023

Journal Articles

To Study Outcomes in Young CML Treated with TKI. a Registry Data from Hematological Cancer Consortium (HCC) of India

Blood (2023) 142 (Supplement 1): 4542.

https://doi.org/10.1182/blood-2023-181369

Published: 2023

Journal Articles

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Blood (2023) 142 (Supplement 1): 5513.

https://doi.org/10.1182/blood-2023-184564

Published: 2023

Journal Articles

Acute Myeloid Leukemia during the COVID Pandemic: Impact and the Indian Experience

Blood (2022) 140 (Supplement 1): 8127–8128.

https://doi.org/10.1182/blood-2022-165770

Published: 2022

Journal Articles

Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study (pRISM) of the Hematology Cancer Consortium (HCC)

Blood (2022) 140 (Supplement 1): 3223–3224.

https://doi.org/10.1182/blood-2022-169001

Published: 2022

Journal Articles

Intracranial Bleeding in Acute Promyelocytic Leukemia Treated with Arsenic Trioxide-Based Regimens: Impact on Relapse and Survival

Uday Prakash Kulkarni, Sushil Selvarajan, Fouzia NA, Sharon Lionel, Sukesh C Nair, Poonkuzhali Balasubramanian, Thenmozhi Mani, Aby Abraham, Biju George, Vikram Mathews

Blood (2022) 140 (Supplement 1): 8917–8918.

https://doi.org/10.1182/blood-2022-168649

Published: 2022

Journal Articles

Prognostic Factors and Outcomes of Adolescent and Adult Burkitt Lymphoma and Leukemiafrom a Low-Middle Income Country: An Experience from Hematology Cancer Consortium

Blood (2022) 140 (Supplement 1): 6687–6689.

https://doi.org/10.1182/blood-2022-165840

Published: 2022

Journal Articles

Real World Data on Unique Challenges and Outcomes of Older Patients with AML from Resource Limited Settings: Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)

Blood (2022) 140 (Supplement 1): 6096–6098.

https://doi.org/10.1182/blood-2022-167099

Published: 2022

Journal Articles

Real-World Outcomes for Acute Promyelocytic Leukemia: Need to Address Induction Mortality

Manju Sengar, Hasmukh Jain, Uday Prakash Kulkarni, Vasu Babu Goli, Anu Korula, Prasanna Samuel, Sushil Selvarajan, Lingaraj Nayak, Aby Abraham, Om Prakash, Fouzia N., Saranya Kumaran, Jayashree Thorat, Bhausaheb Bagal, Poonkuzhali Balasubramanian, Dhanlaxmi Shetty, Nikhil Patkar, Biju George, Vikram Mathews

Blood (2022) 140 (Supplement 1): 3244–3245.

https://doi.org/10.1182/blood-2022-167202

Published: 2022

Journal Articles

Real World Data of Concurrent Arsenic Trioxide and All-Trans Retinoic Acid with Minimal Use of Anthracycline in the Treatment of Acute Promyelocytic Leukemia

Uday Prakash Kulkarni, Sushil Selvarajan, Sharon Lionel, Mithun Abraham Prakash, Hamenth Kumar Palani, Nithya Balasundaram, Arvind Venkatraman, Anu Korula, Anup J Devasia, Fouzia NA, Nancy Beryl Janet, Sukesh Chandran Nair, Aby Abraham, Thenmozhi Mani, Jeyaseelan Lakshmanan, Arun Kumar Arunachalam, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews

Blood (2021) 138 (Supplement 1): 2338.

https://doi.org/10.1182/blood-2021-146362

Published: 2021

NARROW

Safety, Efficacy and Total Cost of Therapy of Decentralized, Point-of-Care Manufactured Anti-CD19 CAR-T Cells for Relapsed or Refractory B Cell Leukemia and Lymphoma: Results from the First Phase 1 Indian Trial (VELCART)

Factor VIII Expression from a Novel F8 Transgene through a Lentiviral Vector Transduced CD34+ Autologous Hematopoietic Stem Cells for Gene Therapy of Severe Hemophilia Α: Final Results from a Phase 1 Clinical Trial

Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma

Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Impact of Consolidation Radiotherapy in Bulky Diffuse Large B Cell Lymphoma By PET Based Response Assessment

EASIX d0 Predicts Early Transplant-Related Mortality in Patients Undergoing Haploidentical Transplantation with Post-Transplant Cyclophosphamide-Mycophenolate Mofetil-Based GvHD Prophylaxis

Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Patterns of Care and Outcome in Adolescent and Young Adults (AYA) Lymphomas- a Multicenter HCC (Hematologic Cancer Consortium) Registry Study from India

Outcomes of Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia: An Indian Multi-Institution, Prospective Study from the Haematology Cancer Consortium (HCC)

Outcomes and Prognostic Factors in Patients with Primary Mediastinal B Cell Lymphoma: An Experience from Hematology Cancer Consortium

To Study Outcomes in Young CML Treated with TKI. a Registry Data from Hematological Cancer Consortium (HCC) of India

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Acute Myeloid Leukemia during the COVID Pandemic: Impact and the Indian Experience

Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study (pRISM) of the Hematology Cancer Consortium (HCC)

Intracranial Bleeding in Acute Promyelocytic Leukemia Treated with Arsenic Trioxide-Based Regimens: Impact on Relapse and Survival

Prognostic Factors and Outcomes of Adolescent and Adult Burkitt Lymphoma and Leukemiafrom a Low-Middle Income Country: An Experience from Hematology Cancer Consortium

Real World Data on Unique Challenges and Outcomes of Older Patients with AML from Resource Limited Settings: Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)

Real-World Outcomes for Acute Promyelocytic Leukemia: Need to Address Induction Mortality

Real World Data of Concurrent Arsenic Trioxide and All-Trans Retinoic Acid with Minimal Use of Anthracycline in the Treatment of Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only